We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals

593 hedge funds and large institutions have $30.1B invested in Alnylam Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 239 increasing their positions, 180 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more first-time investments, than exits

New positions opened: 98 | Existing positions closed: 62

33% more repeat investments, than reductions

Existing positions increased: 239 | Existing positions reduced: 180

17% more call options, than puts

Call options by funds: $195M | Put options by funds: $166M

5% more funds holding

Funds holding: 566593 (+27)

2.61% more ownership

Funds ownership: 96.47%99.08% (+2.6%)

12% less capital invested

Capital invested by funds: $34.1B → $30.1B (-$3.99B)

43% less funds holding in top 10

Funds holding in top 10: 74 (-3)

Holders
593
Holders Change
+27
Holders Change %
+4.77%
% of All Funds
7.81%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.05%
New
98
Increased
239
Reduced
180
Closed
62
Calls
$195M
Puts
$166M
Net Calls
+$29M
Net Calls Change
-$10.2M